A nurse is caring for a client who has sickle cell disease.
For each client finding, click to specify if the finding is consistent with sickle cell disease, iron deficiency anemia. or leukemia. Each finding may support more than 1 disease process.
Jaundice
Respiratory status
Ankle ulcer
Joint pain
Heart rate at 1000
The Correct Answer is {"A":{"answers":"A"},"B":{"answers":"A,C"},"C":{"answers":"A"},"D":{"answers":"A,C"},"E":{"answers":"A,B,C"}}
Rationale Assessment Findings Jaundice
Sickle Cell Disease: Yes. Jaundice occurs due to hemolysis of red blood cells, which is common in sickle cell disease as the sickled cells break down more rapidly than normal red blood cells.
Iron Deficiency Anemia: No. Jaundice is not a characteristic finding of iron deficiency anemia. Leukemia: No. Jaundice is not typically associated with leukemia.
Respiratory Status
Sickle Cell Disease: Yes. Clients may experience dyspnea and labored breathing due to vaso-occlusive crises, which can lead to lung involvement (acute chest syndrome).
Iron Deficiency Anemia: No. While severe anemia can lead to fatigue and shortness of breath, it does not typically cause labored breathing as a primary finding.
Leukemia: Yes. Respiratory issues can arise if leukemia causes significant bone marrow infiltration or if there is an infection due to immunosuppression.
Ankle Ulcer
Sickle Cell Disease: Yes. Chronic ulcers are common in sickle cell disease due to poor circulation and vaso-occlusive episodes.
Iron Deficiency Anemia: No. Ankle ulcers are not a characteristic finding in iron deficiency anemia. Leukemia: No. While leukemia can lead to skin issues or infections, ulcers are not a typical finding. Joint Pain
Sickle Cell Disease: Yes. Joint pain is a common symptom due to vaso-occlusive crises, where sickled cells block blood flow to the joints.
Iron Deficiency Anemia: No. Joint pain is not a common symptom of iron deficiency anemia.
Leukemia: Yes. Joint pain can occur due to leukemic infiltration of the bone marrow or as a side effect of treatments.
Heart Rate at 1000 (112/min)
Sickle Cell Disease: Yes. Tachycardia can occur in response to pain, hypoxia, or anemia due to sickle cell disease.
Iron Deficiency Anemia: Yes. Increased heart rate can occur as the body compensates for decreased hemoglobin and oxygen-carrying capacity.
Leukemia: Yes. Tachycardia can also be seen in leukemia, particularly if the patient is anemic or experiencing systemic effects of the disease.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["B","C","E"]
Explanation
A. This test measures the blood's capacity to bind iron with transferrin, and it is primarily used to evaluate iron metabolism and diagnose iron deficiency anemia. It is not specifically used for diagnosing CML. Therefore, this option is not typically relevant for CML testing.
B. This test is used to detect specific genetic abnormalities associated with CML, particularly the Philadelphia chromosome, which results from a translocation between chromosomes 9 and 22. FISH is a valuable diagnostic tool for identifying the presence of this genetic marker, making this a relevant test for CML.
C. This test examines the chromosomes in cells and is crucial for diagnosing CML. It allows for the detection of chromosomal abnormalities, including the Philadelphia chromosome. Cytogenetic analysis is a standard diagnostic tool in identifying CML and monitoring treatment response.
D. A reticulocyte count measures the number of young red blood cells in the blood and is used to assess bone marrow function. While it can provide some information about bone marrow activity, it is not specific for diagnosing CML. Therefore, it is not a primary diagnostic test for this condition.
E. RT-PCR is a highly sensitive test that detects the BCR-ABL fusion gene, which is characteristic of CML. This test is used not only for diagnosis but also for monitoring treatment response. It is a critical test in the management of CML.
Correct Answer is D
Explanation
A. A specialized chemotherapy mask is not typically required for the administration of oral chemotherapy. Masks may be necessary during certain procedures (like administering intravenous chemotherapy) where there is a risk of splashing or aerosolization, but they are not standard for oral administration.
B. A chemotherapy gown is generally not required for administering oral chemotherapy. These gowns are used for intravenous chemotherapy administration where there is a risk of drug spillage. For oral medications, the risk of exposure is significantly lower, so gowns are not standard practice.
C. A face shield is not typically needed when administering oral chemotherapy. Face shields are used to protect against splashes during procedures involving injectable forms of chemotherapy or other hazardous drugs, but oral administration does not pose the same risk of exposure.
D. The use of chemotherapy gloves is essential when handling oral chemotherapy agents. Gloves protect the nurse from potential exposure to the medication, especially if the drug is crushed or if there is any risk of spillage.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.